Research Keyword: antifungal therapy

Invasive fungal otitis media with peripheral facial paralysis

This case describes a rare fungal ear infection caused by Aspergillus fumigatus that spread to the mastoid bone and caused facial nerve paralysis. The patient had ear drainage and hearing loss for 4 years before diagnosis. Treatment required two surgical procedures to remove infected tissue combined with 6 months of antifungal medication, eventually resulting in healing and recovery of facial nerve function.

Read More »

Invasive Cutaneous Mucormycosis in a Patient With Chronic Lymphocytic Leukemia on Obinutuzumab, Idelalisib, and Bruton Tyrosine Kinase Degrader: A Case Report

A 74-year-old man with blood cancer developed a serious fungal skin infection caused by Mucorales while taking multiple targeted cancer drugs. The infection appeared as a darkening ulcer on his ankle that rapidly worsened. Doctors diagnosed it using a skin biopsy showing characteristic fungal structures, though standard fungal tests came back negative. The patient required amputation of his leg below the knee to remove all the infected tissue, along with antifungal medications, and ultimately recovered.

Read More »

Clinical spectrum, immune status, and prognostic factors of cryptococcosis: insights from a large, multi-center, ambispective cohort study in southeastern China

This study examined cryptococcosis, a serious fungal infection, in 396 non-HIV patients across hospitals in southeastern China. The researchers found that patients’ immune status, whether the infection spread to the brain, and blood inflammation markers were key predictors of survival. Most patients treated with azole medications (a common antifungal) improved or recovered, though those with brain involvement or severe immune deficiency had worse outcomes. The findings help doctors identify which patients need more intensive treatment.

Read More »

A rare case of invasive necrotizing myositis of the thigh caused by Basidiobolus ranarum: a multi-pronged approach to successfully managing a near-fatal polybacterial mycotic infection

A 46-year-old man developed a severe fungal infection caused by a rare fungus called Basidiobolus ranarum in his thigh, which started from an insect bite two years earlier. The infection caused tissue death and was complicated by bacterial superinfection, requiring aggressive treatment with multiple antibiotics and antifungal medications along with several surgeries. Doctors used a combination approach including voriconazole, potassium iodide, and itraconazole to finally control the infection, though amputation was necessary due to the extent of tissue damage. The case highlights the importance of early medical care and demonstrates that rare fungal infections can be life-threatening even in otherwise healthy people.

Read More »

Approaches to Invasive Fungal Diseases in Paediatric Cancer Centres: An Analysis of Current Practices and Challenges in Germany, Austria and Switzerland

This research examined how pediatric cancer hospitals in Germany, Austria, and Switzerland manage fungal infections, which are a serious risk for children undergoing cancer treatment. The survey found that while most hospitals have infection specialists and antifungal prevention strategies, there are significant differences in how they diagnose and treat these infections. The study identified key challenges like drug interactions and delays in testing, and suggests that better networks between cancer and infection specialists could improve patient care.

Read More »

Randomized control trial to study the effectiveness of tablet Fluconazole, capsule Itraconazole and tablet Terbinafine in superficial dermatophytosis

This study tested three common antifungal medications used to treat fungal skin infections like ringworm. The research involved 180 patients who were randomly given one of three drugs and then checked at 4 and 8 weeks to see if the infection was gone. Itraconazole worked best, clearing infections in about 87% of patients, followed by Fluconazole at 73%, and Terbinafine at 63%.

Read More »

Histoplasma capsulatum prosthetic valve endocarditis treated with oral isavuconazole

A 76-year-old man developed a rare fungal infection of his artificial heart valve caused by Histoplasma capsulatum. After surgically replacing the infected valve, he was treated with isavuconazole, an antifungal medication taken by mouth. Unlike traditional antifungal treatments, isavuconazole was better tolerated and easier to take. The patient successfully recovered after nine months of treatment with no complications.

Read More »

Candida krusei Empyema: A Lung Transplant Case and Systematic Review of the Literature

Candida krusei is a dangerous fungus that can cause fluid buildup around the lungs (empyema), particularly in transplant patients. Unlike common fungal infections that respond to fluconazole, this species is naturally resistant to this drug, making it harder to treat. The fungus forms protective biofilms that shield it from treatment, requiring combination antifungal medications and sometimes surgery to drain the fluid and remove infected tissue for successful recovery.

Read More »

Efficacy of Rezafungin on Candida albicans Endophthalmitis in a Rabbit Model

Researchers tested a new antifungal drug called rezafungin against a serious eye infection caused by Candida fungus in rabbits. Rezafungin performed much better than two other commonly used antifungal drugs, completely eliminating the fungus from the eye while preventing infection-related damage. The drug’s ability to be given weekly instead of daily makes it more practical for treating patients with severe fungal eye infections.

Read More »

Diversity and Distribution of Fungal Infections in Rwanda: High Risk and Gaps in Knowledge, Policy, and Interventions

This comprehensive review reveals that Rwanda faces significant challenges from fungal infections affecting humans, crops, and food security, yet has very limited systems to detect, report, or manage these infections. The study found various dangerous fungi causing infections ranging from vaginal candidiasis to serious disseminated infections, as well as crop-destroying soil fungi threatening bean production. The researchers emphasize that Rwanda urgently needs better diagnostic tools, trained healthcare workers, and coordinated public health strategies to combat the growing threat of fungal diseases.

Read More »
Scroll to Top